2/17
12:56 pm
MRNA
Rating for MRNA
Low
Report
Rating for MRNA
2/17
12:56 pm
MRNA
Rating for MRNA
Low
Report
Rating for MRNA
2/17
12:56 pm
MRNA
Rating for MRNA
Low
Report
Rating for MRNA
2/17
12:14 pm
MRNA
Rating for MRNA
Low
Report
Rating for MRNA
2/17
12:14 pm
MRNA
Rating for MRNA
Low
Report
Rating for MRNA
2/17
10:05 am
MRNA
Moderna (NASDAQ:MRNA) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada.
Low
Report
Moderna (NASDAQ:MRNA) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada.
2/17
10:05 am
MRNA
Moderna (NASDAQ:MRNA) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada.
Low
Report
Moderna (NASDAQ:MRNA) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada.
2/17
09:47 am
MRNA
Rating for MRNA
Low
Report
Rating for MRNA
2/17
08:02 am
MRNA
Moderna (NASDAQ:MRNA) had its "market perform" rating reaffirmed by analysts at Sanford C. Bernstein.
Medium
Report
Moderna (NASDAQ:MRNA) had its "market perform" rating reaffirmed by analysts at Sanford C. Bernstein.
2/16
08:11 am
MRNA
Moderna (NASDAQ:MRNA) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
Medium
Report
Moderna (NASDAQ:MRNA) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
2/16
08:05 am
MRNA
Moderna (NASDAQ:MRNA) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
Moderna (NASDAQ:MRNA) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..
1/30
08:02 am
MRNA
Moderna (NASDAQ:MRNA) had its "underperform" rating reaffirmed by analysts at Leerink Partners.
Medium
Report
Moderna (NASDAQ:MRNA) had its "underperform" rating reaffirmed by analysts at Leerink Partners.
1/28
08:03 am
MRNA
Moderna (NASDAQ:MRNA) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $25.00 price target on the stock.
Low
Report
Moderna (NASDAQ:MRNA) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $25.00 price target on the stock.
1/19
01:04 pm
MRNA
Moderna (NASDAQ:MRNA) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Moderna (NASDAQ:MRNA) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..
1/12
04:11 pm
MRNA
Moderna (NASDAQ:MRNA) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada.
High
Report
Moderna (NASDAQ:MRNA) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada.
1/12
04:11 pm
MRNA
Moderna (NASDAQ:MRNA) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada.
High
Report
Moderna (NASDAQ:MRNA) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada.
1/12
04:11 pm
MRNA
Moderna (NASDAQ:MRNA) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to a "buy" rating.
High
Report
Moderna (NASDAQ:MRNA) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to a "buy" rating.
1/7
08:23 am
MRNA
Rating for MRNA
Low
Report
Rating for MRNA
1/6
05:04 pm
MRNA
Moderna (NASDAQ:MRNA) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating.
Low
Report
Moderna (NASDAQ:MRNA) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating.
12/12
12:16 pm
MRNA
Rating for MRNA
Low
Report
Rating for MRNA
12/12
12:16 pm
MRNA
Rating for MRNA
Low
Report
Rating for MRNA
12/12
08:24 am
MRNA
Rating for MRNA
Low
Report
Rating for MRNA
12/12
08:24 am
MRNA
Rating for MRNA
Low
Report
Rating for MRNA
12/11
07:59 pm
MRNA
Moderna initiated with a Hold at Jefferies
Low
Report
Moderna initiated with a Hold at Jefferies
12/11
07:59 pm
MRNA
Moderna initiated with a Hold at Jefferies
Low
Report
Moderna initiated with a Hold at Jefferies